Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,106 | 148,011 | 131,973 | 68,131 | 218,044 |
| Marketable Securities | 907,405 | 961,245 | 1,059,014 | 1,220,322 | 1,118,171 |
| TOTAL | $1,064,137 | $1,142,884 | $1,224,062 | $1,325,162 | $1,372,319 |
| Non-Current Assets | |||||
| PPE Net | 45,589 | 48,101 | 39,821 | 42,117 | 44,087 |
| Investments And Advances | 0 | 7,905 | 0 | 0 | 0 |
| Other Non-Current Assets | 44,191 | 37,887 | 41,851 | 42,065 | 43,836 |
| TOTAL | $89,780 | $93,893 | $81,672 | $84,182 | $87,923 |
| Total Assets | $1,153,917 | $1,236,777 | $1,305,734 | $1,409,344 | $1,460,242 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,483 | 1,182 | 8,520 | 2,215 | 2,790 |
| Accrued Expenses | 68,499 | 36,286 | 35,986 | 76,666 | 66,691 |
| Other current liabilities | N/A | 26,698 | 18,077 | 305,660 | 294,441 |
| TOTAL | $77,982 | $71,180 | $69,357 | $391,080 | $363,922 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,981 | 47,266 | 49,552 | 51,558 | 53,890 |
| TOTAL | $44,981 | $47,266 | $49,552 | $51,558 | $53,890 |
| Total Liabilities | $122,963 | $118,446 | $118,909 | $442,638 | $417,812 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,160 | 138,197 | 137,422 | 136,889 | 136,678 |
| Common Shares | 1,711 | 1,707 | 1,700 | 1,694 | 1,686 |
| Retained earnings | -1,116,211 | -996,738 | -897,385 | -1,080,768 | -970,987 |
| Other shareholders' equity | 643 | -651 | -1,441 | -2,517 | -6,886 |
| TOTAL | $1,030,954 | $1,118,331 | $1,186,825 | $966,706 | $1,042,430 |
| Total Liabilities And Equity | $1,153,917 | $1,236,777 | $1,305,734 | $1,409,344 | $1,460,242 |